九安医疗：公司已完成持续血糖监测（CGM）领域多批次试生产，目前已在国内积极开展型检和临床相关工作

Group 1 - The company has completed multiple batches of pilot production for continuous glucose monitoring (CGM) devices and is actively conducting clinical-related work domestically [1] - The company is also advancing the research and development of CGM products for international markets [1] - The CGM product will be integrated into a new "O+O" model for diabetes diagnosis and care, which is expected to accelerate the implementation and development of the company's core strategy [1] Group 2 - The company aims to create a high-frequency, sticky customer base through effective service in the "O+O" model, which can generate good synergy effects [1]